메뉴 건너뛰기




Volumn 245, Issue 11, 2007, Pages 1723-1725

Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab

Author keywords

Best's disease; Bevacizumab; Childhood; Choroidal neovascularisation; Intravitreal injection; Vascular endothelial growth factor; Vitelliform dystrophy of the macula

Indexed keywords

BEVACIZUMAB;

EID: 34848893335     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0604-7     Document Type: Article
Times cited : (61)

References (5)
  • 2
    • 0345304309 scopus 로고    scopus 로고
    • Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease
    • Andrade RE, Farah ME, Costa RA (2003) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Am J Ophthalmol 136:1179-1181
    • (2003) Am J Ophthalmol , vol.136 , pp. 1179-1181
    • Andrade, R.E.1    Farah, M.E.2    Costa, R.A.3
  • 4
    • 2942674820 scopus 로고    scopus 로고
    • Treatment of cystoid macular edema with oral acetazolamide in a patient with best vitelliform macular dystrophy
    • Hori K, Ishida S, Inoue M, Shinoda K, Kawashima S, Kitamura S, Oguchi Y (2004) Treatment of cystoid macular edema with oral acetazolamide in a patient with best vitelliform macular dystrophy. Retina 24:481-482
    • (2004) Retina , vol.24 , pp. 481-482
    • Hori, K.1    Ishida, S.2    Inoue, M.3    Shinoda, K.4    Kawashima, S.5    Kitamura, S.6    Oguchi, Y.7
  • 5
    • 33748979577 scopus 로고    scopus 로고
    • Antivascular endothelial growth factor agents and their development: Therapeutic implications in ocular diseases
    • Kaiser PK (2006) Antivascular endothelial growth factor agents and their development: Therapeutic implications in ocular diseases. Am J Ophthalmol 2006 142:660-668
    • (2006) Am J Ophthalmol , vol.142 , pp. 660-668
    • Kaiser, P.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.